Keto Diet Beats Mediterranean Diet in Liver Fat Reduction, Study Finds

A recent clinical study published in the journal Cell Metabolism reveals that a ketogenic diet reduces liver fat by an average of 67% over four to five months, significantly outperforming both Mediterranean and low-fat diets in participants with obesity, pre-diabetes, and non-alcoholic fatty liver disease.

Clinical Efficacy and Metabolic Mechanisms in Fatty Liver Disease

Researchers at the Washington University School of Medicine tracked participants carefully assigned to distinct nutritional interventions. While all diet groups achieved an average body weight reduction of approximately 10% over the four-to-five-month period, the physiological impact on hepatic lipid accumulation varied dramatically based on macronutrient composition. According to findings covered by Rádio Itatiaia, the very-low-carbohydrate ketogenic regimen restricted carbohydrate intake to just 4% of total daily calories.

In contrast, the Mediterranean diet and the low-fat diet groups consumed 50% and 70% of their daily calories from carbohydrates, respectively. The mechanism of action driving the superior hepatic outcome in the ketogenic cohort involves a marked suppression of circulating insulin levels coupled with a substantial elevation in glucagon—a peptide hormone secreted by the pancreas that stimulates the mobilization and oxidation of stored hepatic fat.

In Plain English: The Clinical Takeaway

• Targeted Fat Loss: Cutting carbs down to just 4% of daily intake clears fat out of the liver nearly 50% better than traditional Mediterranean or low-fat diets, even when total weight loss is the same.
• Hormonal Shifts: Lower insulin and higher glucagon levels work together to stop the liver from storing excess fat and force it to burn what is already there.
• Blood Sugar Control: The severe carb restriction helped half of the study’s pre-diabetic participants normalize their blood sugar markers, reversing their pre-diabetes status.

Comparative Trial Data and Glycemic Resolution

Beyond hepatic steatosis (fatty liver disease), the trial tracked systemic metabolic markers, most notably glycemic control among participants with pre-diabetes. Citing data from Rádio Itatiaia, approximately 50% of the individuals following the ketogenic protocol successfully exited the pre-diabetes diagnostic threshold by the conclusion of the intervention. This starkly contrasts with the Mediterranean diet group, where 29% resolved their pre-diabetes, and the low-fat cohort, which saw a mere 7% reversion rate.

Dietary Intervention	Carbohydrate Intake (% of Calories)	Average Liver Fat Reduction (%)	Pre-Diabetes Resolution Rate (%)
Ketogenic Diet	4%	67%	50%
Mediterranean Diet	50%	45%	29%
Low-Fat Diet	70%	45%	7%

All participants underwent weekly nutritional counseling and monitoring to ensure strict compliance with their assigned caloric and macronutrient guidelines. These methodological controls help isolate dietary composition as the primary variable responsible for the superior metabolic recovery observed in the ketogenic arm.

Translational Outlook and Future Research Directions

The findings from Washington University underscore the clinical importance of prioritizing dietary quality and metabolic phenotype over simple scale weight when treating obesity-associated comorbidities.

Photo: omniletters.com

References

• Cell Metabolism. Washington University School of Medicine. Clinical trial findings on very-low-carbohydrate interventions in hepatic steatosis and pre-diabetes.
• Rádio Itatiaia. Coverage of comparative dietary trials and hepatic lipid metabolism.